Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keratinocyte growth factor in Acute Lung Injury to Reduce Pulmonary Dysfunction (KARE)
2010-021186-70Phase 2Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Oct 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute lung injury (ALI) comparing Palifermin with Placebo (2 arms). Primary endpoint: Primary. Started Oct 2010; status: completed.
02
Drugs
palifermin
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on 2010-021186-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021186-70.